1Neoptolemos,J P,Cunningham D,Friess,H.et al. Adjuvant therapy in pancreatic cancer[J].historical and current perspectives.Annals of ontology,2003,14(5):675-692.
2RautCP,Au Al M,Staerkel GA,et al. Diagnostic accuracy of endoscopic Ultrosound guraided fine needle aspiration inpatients with presumed pancreatic cancer[J].JGastromtest Surg,2003,7(1): 118- 126.
3Japan pancreas Society.Classification of pancreatic carcinoma, 1st ed[M].Tokyo: Kanehara Shuppan Company Press, 1996 : 2-8.
4Arey LB .The pancreas in developmental anatomy,7th ed[M].Philadelphiaand London : W.B.Saunders Company Press, 1974 : 259-262.
5Mitsutsuji M, Suzuki Y, Iwanaga Y, et al.An experimental study on thepharmacokinetics of 5-fluomuracil regional chemotherapy for pancreaticcancer[J].Ann Surg Oncol, 2003,10 : 546-550.
6Shamseddine Al, Khalifeh MJ, Mourad FH, et al.Comparative inpharmacokinetics and metabolic pathway of gemeitabine during intravenousand intra—arterial delivery in unresectable pancreatic cancer patients[J].Clinpharmacokinet, 2005,44 : 957-967.
